Comment on

• Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.

  [No authors listed] [No authors listed] Lancet. 1998 Nov 7;352(9139):1498-504. Lancet. 1998. PMID: 9820297 Clinical Trial.
• Interferons in relapsing remitting multiple sclerosis: a systematic review.

  Filippini G, Munari L, Incorvaia B, Ebers GC, Polman C, D'Amico R, Rice GP. Filippini G, et al. Lancet. 2003 Feb 15;361(9357):545-52. doi: 10.1016/S0140-6736(03)12512-3. Lancet. 2003. PMID: 12598138